BLISS GVS PHARMA LTD. - Announcement under Regulation 30 (LODR)-Credit Rating

Download	< Back
19 Jun 2024
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. SEBI/HO/CFD/CSD-PoD-1/P/CIR/2023/123 dated July 13, 2023, we would like to inform you that, CRISIL Ratings Limited vide its press releases dated June 19, 2024 bearing ref. no. RL/GDS2784/346423/BLR/0624/91401, has reaffirmed/assigned the ratings outstanding for the debt instruments/facilities of the Company, and the rating actions by CRISIL Ratings on the ratings as on date. Enclosed herewith intimation on the same.
View all announcements for BLISS GVS PHARMA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us